These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12771064)

  • 1. QALYs: the best option so far.
    Chong CA
    CMAJ; 2003 May; 168(11):1394-6; author reply 1396. PubMed ID: 12771064
    [No Abstract]   [Full Text] [Related]  

  • 2. Calculation of quality adjusted life years in the published literature: a review of methodology and transparency.
    Richardson G; Manca A
    Health Econ; 2004 Dec; 13(12):1203-10. PubMed ID: 15386669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Legislating against use of cost-effectiveness information.
    Neumann PJ; Weinstein MC
    N Engl J Med; 2010 Oct; 363(16):1495-7. PubMed ID: 20942664
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome measurement in economic evaluation.
    Johannesson M; Jönsson B; Karlsson G
    Health Econ; 1996; 5(4):279-96. PubMed ID: 8880165
    [No Abstract]   [Full Text] [Related]  

  • 5. Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey.
    Franic DM; Pathak DS; Gafni A
    J Clin Epidemiol; 2005 Mar; 58(3):291-303. PubMed ID: 15718119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is cost-effectiveness analysis unfair?
    Russell LB
    Med Decis Making; 2004; 24(2):232-4. PubMed ID: 15090108
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of quality-adjusted life-years in cost-effectiveness studies.
    Sculpher M
    Allergy; 2006 May; 61(5):527-30. PubMed ID: 16629779
    [No Abstract]   [Full Text] [Related]  

  • 8. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-utility analysis of chronic spinal pain treatment outcomes: converting SF-36 data into quality-adjusted life years.
    Hatten AL; Gatchel RJ; Polatin PB; Stowell AW
    Clin J Pain; 2006 Oct; 22(8):700-11. PubMed ID: 16988566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating feelings related to the uncertainty about future health in utility measurement.
    Gandjour A
    Health Econ; 2008 Oct; 17(10):1207-13. PubMed ID: 18074407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What do utilities measure?
    Tsevat J
    Med Care; 2000 Sep; 38(9 Suppl):II160-4. PubMed ID: 10982102
    [No Abstract]   [Full Text] [Related]  

  • 13. Measuring outcomes in palliative care: limitations of QALYs and the road to PalYs.
    Normand C
    J Pain Symptom Manage; 2009 Jul; 38(1):27-31. PubMed ID: 19615624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decision processes in the management of dental disease. Part 1: QALYs, QATYs and dental health state utilities.
    Fyffe HE; Nuttall NM
    Dent Update; 1995 Mar; 22(2):67-71. PubMed ID: 10495696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating QALYs with a heavy dose of social values: is the cure worth the cost?
    Matchar DB
    Med Care; 2000 Sep; 38(9):889-91. PubMed ID: 10982110
    [No Abstract]   [Full Text] [Related]  

  • 16. Equity weights in the allocation of health care: the rank-dependent QALY model.
    Bleichrodt H; Diecidue E; Quiggin J
    J Health Econ; 2004 Jan; 23(1):157-71. PubMed ID: 15154692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHARMAC's updated guidelines for cost-utility analyses, with new QALYs per $1M metric.
    Grocott R; Metcalfe S
    N Z Med J; 2012 Jul; 125(1358):89-90. PubMed ID: 22864151
    [No Abstract]   [Full Text] [Related]  

  • 18. German recommendations on health economic evaluation: third and updated version of the Hanover Consensus.
    Graf von der Schulenburg JM; Greiner W; Jost F; Klusen N; Kubin M; Leidl R; Mittendorf T; Rebscher H; Schoeffski O; Vauth C; Volmer T; Wahler S; Wasem J; Weber C;
    Value Health; 2008; 11(4):539-44. PubMed ID: 18194408
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-utility analysis of cataract surgery in the second eye.
    Busbee BG; Brown MM; Brown GC; Sharma S
    Ophthalmology; 2003 Dec; 110(12):2310-7. PubMed ID: 14644712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axioms for health care resource allocation.
    Osterdal LP
    J Health Econ; 2005 Jul; 24(4):679-702. PubMed ID: 15960991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.